New York A 482: Enacts the lab services accessibility act

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A00482 Summary:

BILL NOA00482A

&nbsp

SAME ASSAME AS S03356-A

&nbsp

SPONSORClark

&nbsp

COSPNSRStirpe, Levenberg, McDonald, Reyes, Lupardo

&nbsp

MLTSPNSR

&nbsp

Amd §§585 & 586, Pub Health L

&nbsp

Enacts the lab services accessibility act.

Go to top A00482 Actions:

BILL NOA00482A

&nbsp

01/08/2025referred to health

05/01/2025amend and recommit to health

05/01/2025print number 482a

01/07/2026referred to health

Go to topA00482 Committee&nbspVotes:

Go to topA00482 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA00482 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 482--A

 2025-2026 Regular Sessions

 IN ASSEMBLY

 (Prefiled)

 January 8, 2025
 ___________

 Introduced by M. of A. CLARK, STIRPE, LEVENBERG -- read once and
 referred to the Committee on Health -- committee discharged, bill
 amended, ordered reprinted as amended and recommitted to said commit-
 tee

 AN ACT to amend the public health law, in relation to enacting the lab
 services accessibility act

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Short title. This act shall be known and may be cited as
 2 the "lab services accessibility act".
 3 § 2. Section 585 of the public health law, as added by chapter 803 of
 4 the laws of 1992, is amended to read as follows:
 5 § 585. Definitions. Whenever used in this title:
 6 1. "Health services purveyor" means any person, firm, partnership,
 7 group, association, corporation or professional corporation, or any
 8 agent, employee, fiduciary, employer or representative thereof, includ-
 9 ing but not limited to a physician, dentist, podiatrist or chiropractor,
 10 either in individual practice, group practice or employed in a facility
 11 owned by any person, group, association, firm, partnership or corpo-
 12 ration hiring any of the aforementioned practitioners, who provide
 13 health or health related services.
 14 2. "Clinical laboratory" shall have the same meaning as is set forth
 15 in subdivision one of section five hundred seventy-one of this article.
 16 3. "Health services facilitator" means any person, firm, partnership,
 17 group, association, nonprofit corporation, business corporation, profes-
 18 sional corporation, limited liability company, or any agent, employee,
 19 fiduciary, employer or representative thereof, that assists in facili-
 20 tating the provision of health related services, including, but not
 21 limited to, participation in the initiation, coordination, payment,
 22 delivery, or follow-up of such health related services.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD02536-02-5

 A. 482--A 2

 1 4. "Public health program" shall mean an initiative under which the
 2 clinical laboratory services are performed in relation to any procedure,
 3 test, assay, or diagnostic where one of the following applies:
 4 (a) it is supported by public health funds, grants, or awards; or
 5 (b) it is reasonably expected to respond to a public health need
 6 recognized by law, regulation, the department, or other applicable guid-
 7 ance, including, but not limited to:
 8 (i) testing with a heightened need for confidentiality, including, but
 9 not limited to, testing related to: (1) a termination of pregnancy, (2)
 10 a sexually transmittable infection, (3) antiretroviral preexposure
 11 prophylaxis (PrEP) or postexposure prophylaxis (PEP); and (4) drug abuse
 12 screening;
 13 (ii) testing recommended by the federal centers for disease control
 14 and prevention guidelines;
 15 (iii) testing with a grade "A" or "B" recommended by the United States
 16 preventative service task force;
 17 (iv) testing provided to advance access to healthcare and improve
 18 patient outcomes for underserved, vulnerable, and/or rural populations;
 19 (v) testing in response to an epidemic, pandemic, outbreak, or other
 20 declared state of emergency; or
 21 (vi) testing performed in connection with a pilot study, research
 22 study, or clinical trial.
 23 § 3. Subdivisions 2 and 3 of section 586 of the public health law, as
 24 added by chapter 803 of the laws of 1992, paragraph (h) of subdivision 2
 25 as amended